Detalhe da pesquisa
1.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Lancet
; 403(10423): 271-281, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38071986
2.
Tezepelumab in patients with allergic and eosinophilic asthma.
Allergy
; 79(5): 1134-1145, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38146651
3.
Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study.
Respiration
; 103(1): 10-21, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38086344
4.
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.
Am J Respir Crit Care Med
; 208(1): 13-24, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37015033
5.
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Eur Respir J
; 61(3)2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36822634
6.
Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma.
Pneumologie
; 77(6): 357-362, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-36384226
7.
[Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS)]. / Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma der Biologics Asthma Response Score (BARS).
Pneumologie
; 77(4): 220-232, 2023 Apr.
Artigo
Alemão
| MEDLINE | ID: mdl-36796422
8.
Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS).
Pneumologie
; 2023 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37625439
9.
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e.âV.] / S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023.
Pneumologie
; 77(8): 461-543, 2023 Aug.
Artigo
Alemão
| MEDLINE | ID: mdl-37406667
10.
Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma.
Respir Res
; 23(1): 45, 2022 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35246123
11.
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
N Engl J Med
; 377(17): 1613-1629, 2017 10 26.
Artigo
Inglês
| MEDLINE | ID: mdl-28893134
12.
Characteristics and treatment regimens across ERS SHARP severe asthma registries.
Eur Respir J
; 55(1)2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31601713
13.
Measurement of Fractional Exhaled Nitric Oxide: Comparison of Three Different Analysers.
Respiration
; 99(1): 1-8, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31288246
14.
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma.
Am J Respir Crit Care Med
; 209(8): 1031-1033, 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38329781
15.
Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.
Eur Respir J
; 53(2)2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30442714
16.
Reply to Lipworth and Chan.
Am J Respir Crit Care Med
; 208(2): 212-213, 2023 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37279366
17.
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.
N Engl J Med
; 372(21): 1987-95, 2015 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25981191
18.
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e.âV.] / Erratum: S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023.
Pneumologie
; 77(8): e3, 2023 Aug.
Artigo
Alemão
| MEDLINE | ID: mdl-38513695
19.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 388(10056): 2128-2141, 2016 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-27609406
20.
Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort.
Eur Respir J
; 59(6)2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35273030